Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Accenture
Merck
Moodys
Citi
Medtronic

Generated: May 27, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,677,358

« Back to Dashboard

Summary for Patent: 6,677,358
Title: NIDDM regimen
Abstract:The present invention discloses a regimen for the treatment of type 2 diabetes, in which the endogenous secretion of insulin is stimulated in connection with meals, by administering a short-acting, oral hypoglycemic agent. Also, the present invention discloses a method of achieving improvement in glycemic control by combined use of repaglinide and metformin in NIDDM patients poorly controlled on metformin alone.
Inventor(s): Muller; Peter Gi.o slashed.rtz (Princeton Junction, NJ)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:09/459,526
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,677,358
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 6,677,358
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Use; Device;

Drugs Protected by US Patent 6,677,358

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,677,358

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark0694/97Jun 13, 1997

International Family Members for US Patent 6,677,358

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 201139 ➤ Try a Free Trial
Australia 7906898 ➤ Try a Free Trial
Germany 69800806 ➤ Try a Free Trial
Denmark 1011673 ➤ Try a Free Trial
European Patent Office 1011673 ➤ Try a Free Trial
European Patent Office 1097710 ➤ Try a Free Trial
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Chinese Patent Office
US Army
US Department of Justice
Johnson and Johnson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.